Olivieri R, Riccobono E, Gonnelli S, Basagni C, Tumbarello M, Cusi M G, Rossolini G M
Health Service Management Board, Health Service Management, Siena University Hospital, Siena, Italy.
Department of Medical Biotechnologies, University of Siena, Siena, Italy.
J Hosp Infect. 2025 Mar;157:10-18. doi: 10.1016/j.jhin.2024.12.003. Epub 2024 Dec 18.
Carbapenem-resistant Enterobacterales, particularly those producing carbapenemase (CPE), pose a major threat to human health, being listed among critical-priority resistant pathogens by the World Health Organization.
To report on a large nosocomial spread of CPE of different species producing Verona integron-encoded metallo-β-lactamase (VIM)-type carbapenemases, and on the infection prevention and control measures that were adopted to combat the spread.
Conventional culture and molecular methods were used for detection and identification of VIM-positive CPE (VIM-CPE) causing infections or colonizing patients or present in environmental specimens. Whole-genome sequencing analysis of selected isolates was performed to investigate clonal relatedness. Basic (active surveillance, contact precautions, close contact screening, cohorting of patients, surface cleaning, hand hygiene) and advanced (weekly point-prevalence surveys for rectal colonization, additional training of healthcare workers, extraordinary ward sanitization, extraordinary maintenance interventions, and environmental microbiological screening, single-use equipment, ward relocation) infection prevention and control (IPC) measures were implemented to combat the spread.
Spread of VIM-CPE involving 151 patients (mostly colonizations) was documented in a single hospital ward from November 2021 to December 2023. The spread involved several different species of Enterobacterales, with clonal expansion documented in some cases. Implementation of basic and advanced IPC measures was temporarily successful at mitigating the spread, but multiple relapses were observed, suggesting the presence of an unidentified environmental reservoir.
VIM-CPE has the potential to cause large and complex nosocomial outbreaks in hospital environments, underscoring the challenges to their control by IPC practices.
耐碳青霉烯类肠杆菌科细菌,尤其是那些产碳青霉烯酶(CPE)的细菌,对人类健康构成重大威胁,被世界卫生组织列为关键优先耐药病原体。
报告不同物种产维罗纳整合子编码金属β-内酰胺酶(VIM)型碳青霉烯酶的CPE在医院的大规模传播情况,以及为遏制传播所采取的感染预防与控制措施。
采用常规培养和分子方法检测和鉴定引起感染、定植于患者或存在于环境标本中的VIM阳性CPE(VIM-CPE)。对选定分离株进行全基因组测序分析以调查克隆相关性。实施了基本(主动监测、接触预防、密切接触筛查、患者分组、表面清洁、手卫生)和高级(每周进行直肠定植点流行率调查、对医护人员进行额外培训、病房特殊消毒、特殊维护干预、环境微生物筛查、一次性设备、病房搬迁)感染预防与控制(IPC)措施以遏制传播。
2021年11月至2023年12月期间,在一家医院的单个病房记录到VIM-CPE传播涉及151名患者(大多数为定植)。传播涉及几种不同的肠杆菌科细菌,在某些情况下有克隆扩增记录。实施基本和高级IPC措施在暂时减轻传播方面取得了成功,但观察到多次复发,提示存在未识别出的环境储存库。
VIM-CPE有可能在医院环境中引发大规模且复杂的医院感染暴发,凸显了通过IPC措施控制它们的挑战。